|
The Journal of Lipid Research, Vol. 40, 275-286, February 1999
Copyright © 1999 by Lipid Research, Inc.
Presecretory degradation of apolipoprotein[a] is mediated by the proteasome pathway
Ann L. Whitea,b,
Bernadette Guerrac,
Jin Wangb, and
Robert E. Lanfordc
a Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75325
b Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, TX 75325
c Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, TX 78245
Correspondence to:
Ann L. White
Plasma levels of atherogenic lipoprotein [a] (Lp[a]) vary over a 1000-fold range and are largely determined by the gene for its unique glycoprotein, apolipoprotein [a] (apo[a]). The apo[a] locus comprises more than 100 alleles, encoding proteins from <300 to >800 kDa. Using primary baboon hepatocyte cultures, we previously demonstrated that differences in the secretion efficiency of apo[a] allelic variants contribute to the variation in plasma Lp[a] levels. In the current study, we investigated the mechanism of apo[a] presecretory degradation. The proteasome inhibitors, acetyl-leucyl-leucyl-norleucinal and lactacystin, prevented apo[a] degradation and increased apo[a] secretion. Transfection with an HA-tagged ubiquitin construct demonstrated the accumulation of ubiquitinated apo[a] in the presence of lactacystin. These results suggest a role for the cytoplasmic proteasome in apo[a] proteolysis. Apo[a] that accumulated intracellularly in the presence of lactacystin remained sensitive to endo-B-N-glucosaminidase H, and apo[a] degradation was reversibly inhibited by brefeldin A, suggesting that transport to a post-endoplasmic reticulum (ER) pre-medial Golgi compartment is required for apo[a] degradation. Newly synthesized apo[a] bound to the ER chaperone calnexin and conditions that enhanced this interaction prevented apo[a] degradation, suggesting that calnexin can protect apo[a] from proteolysis.
These studies provide further support for the role of the proteasome in endoplasmic reticulum quality control, and expand this role to one that influences plasma levels of the atherogenic lipoprotein Lp[a].White, A. L., B. Guerra, J. Wang, and R. E. Lanford. Presecretory degradation of apolipoprotein[a] is mediated by the proteasome pathway. J. Lipid Res. 1999. 40: 275286.
Supplementary key words:
apolipoprotein[a], calnexin, endoplasmic reticulum, proteasome, ubiquitin

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Xu, C. Sztalryd, X. Lu, J. T. Tansey, J. Gan, H. Dorward, A. R. Kimmel, and C. Londos
Post-translational Regulation of Adipose Differentiation-related Protein by the Ubiquitin/Proteasome Pathway
J. Biol. Chem.,
December 30, 2005;
280(52):
42841 - 42847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rubin, F. Paultre, C. H. Tuck, S. Holleran, R. G. Reed, T. A. Pearson, C. M. Thomas, R. Ramakrishnan, and L. Berglund
Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians
J. Lipid Res.,
February 1, 2002;
43(2):
234 - 244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Boedeker, M. H. Doolittle, and A. L. White
Differential effect of combined lipase deficiency (cld/cld) on human hepatic lipase and lipoprotein lipase secretion
J. Lipid Res.,
November 1, 2001;
42(11):
1858 - 1864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, J. Boedeker, H. H. Hobbs, and A. L. White
Determinants of human apolipoprotein [a] secretion from mouse hepatocyte cultures
J. Lipid Res.,
January 1, 2001;
42(1):
60 - 69.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. C. Boedeker, M. Doolittle, S. Santamarina-Fojo, and A. L. White
Role of N-linked carbohydrate processing and calnexin in human hepatic lipase secretion
J. Lipid Res.,
September 1, 1999;
40(9):
1627 - 1635.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Wang and A. L. White
6-Aminohexanoic Acid as a Chemical Chaperone for Apolipoprotein(a)
J. Biol. Chem.,
April 30, 1999;
274(18):
12883 - 12889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Tokunaga, C. Brostrom, T. Koide, and P. Arvan
Endoplasmic Reticulum (ER)-associated Degradation of Misfolded N-Linked Glycoproteins Is Suppressed upon Inhibition of ER Mannosidase I
J. Biol. Chem.,
December 22, 2000;
275(52):
40757 - 40764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. E. Petaja-Repo, M. Hogue, A. Laperriere, S. Bhalla, P. Walker, and M. Bouvier
Newly Synthesized Human delta Opioid Receptors Retained in the Endoplasmic Reticulum Are Retrotranslocated to the Cytosol, Deglycosylated, Ubiquitinated, and Degraded by the Proteasome
J. Biol. Chem.,
February 2, 2001;
276(6):
4416 - 4423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Garner, A. H. Merry, L. Royle, D. J. Harvey, P. M. Rudd, and J. Thillet
Structural Elucidation of the N- and O-Glycans of Human Apolipoprotein(a). ROLE OF O-GLYCANS IN CONFERRING PROTEASE RESISTANCE
J. Biol. Chem.,
June 15, 2001;
276(25):
22200 - 22208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Khanna, M. P. Myers, M. Laine, and D. M. Papazian
Glycosylation Increases Potassium Channel Stability and Surface Expression in Mammalian Cells
J. Biol. Chem.,
August 31, 2001;
276(36):
34028 - 34034.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|